Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹2,583.60
37.80 (1.44%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹19.64K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
30.7
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,500.3+72.2%
52W High₹2,689-3.9%
Current Price
₹2,583.60
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹2,066.88
Upper Circuit₹3,100.32
Reference Price
₹2,583.60
Investment Checklist
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹2821.0
Descending Channel on 1W — target ₹2506.09
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bearish (price up, volume down)
Composite score 43.28 (BUY) with 81.5% confidence
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
82%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
2479.16
EMA50
2254.29
EMA200
2025.44
Price Action
MIXED
NEUTRAL
Higher Highs6
Higher Lows5
Lower Highs3
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹2675.00
Support (Below)
₹2395.00
₹2235.00
₹2162.40
₹2077.78
₹1961.00
Volume Analysis
TrendSTABLE
Change-2.20%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹2557.76
3% Risk₹2506.09
5% Risk₹2454.42
7% Risk (Custom)
₹2402.75Technical Levels
1x ATR (Volatility)₹2483.02
2x ATR (Swing)₹2382.44
3x ATR (Trend)₹2281.86
Immediate Support₹2395.00
Moving Averages
EMA 9 (Short-term)₹2563.44
EMA 20 (Medium-term)₹2479.16
EMA 50 (Trend)₹2254.29
EMA 200 (Long-term)₹2025.44
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹493 Cr | ₹486.2 Cr | ₹510.2 Cr | ₹542.8 Cr |
| Net Profit | ₹139 Cr | ₹142.6 Cr | ₹152.8 Cr | ₹163.9 Cr |
| EPS | ₹18.28 | — | ₹20.10 | ₹21.56 |
| Operating Profit | ₹193.6 Cr | ₹193.9 Cr | ₹200.9 Cr | ₹223.4 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Caplin Point Laboratories Limited | ₹2,583.60 | -1.44% | 30.7 | ₹19.64K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 29 May 2026 | Interim Dividend - Rs 4 Per Share | INTERIM_DIVIDEND |
| 12 Sept 2025 | Dividend - Rs 3 Per Share | DIVIDEND |
| 30 May 2025 | Interim Dividend - Rs 3 Per Share | INTERIM_DIVIDEND |
| 23 Sept 2024 | Annual General Meeting | AGM |
| 23 Sept 2024 | Dividend - Rs 2.50 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for CAPLIPOINT
View AllNEWS
positive
Business Standard - Markets 31d ago
Caplin Point Lab jumps over 20% in five days
Caplin Point Laboratories surged 5.18% to Rs 2,374.45 on Tuesday, extending its winning streak to a fifth consecutive session.
CAPLIPOINTHealthcare
neutral
Google News - India Markets 49d ago
Caplin Point to attend TRINITY INDIA 2026 on May 28 - scanx.trade
Caplin Point to attend TRINITY INDIA 2026 on May 28scanx.trade
CAPLIPOINTHealthcare
NEWS
positive
Business Standard - Markets 56d ago
Caplin Steriles receives USFDA approval for Foscarnet Sodium Injection
Caplin Steriles (CSL), a subsidiary company of Caplin Point Laboratories has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Foscarnet Sodium Injection (6000 mg/250 mL Infusion Bag), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) Foscavir Injection from Clinigen Healthcare, (NDA 020068).
CAPLIPOINTHCGHCG-REHEALTHCARENIDANFinancial ServicesHealthcare